TransFlex human OCT1 (SLC22A1) plates are available in a 96-well format with variable plate configurations. The plates are ready to use after an overnight incubation—no change of medium required.
In the graph above, TransFlex-OCT1 plate performance is demonstrated by the OCT1-mediated transport of MPP+, and the inhibition of that transport by the OCT1 inhibitor quinidine.
|Catalog Number||Plate Configuration|
|TFlex-OCT1||Half of the wells contain OCT1-expressing cells, and half contain control cells.|
|TFlex-OCT1-F||All of the wells contain OCT1-expressing cells.|
|TFlex-MDCK-C||All of the wells contain control cells.|
|TFlex-Pick2||Custom format: plate contains two transporters of your choice, plus control cells.|
|TFlex-Pick4||Custom format: plate contains four transporters of your choice, plus control cells.|
Please contact us for more information.